Jorie Versmissen

3.2k total citations · 1 hit paper
94 papers, 2.0k citations indexed

About

Jorie Versmissen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jorie Versmissen has authored 94 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 30 papers in Surgery and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jorie Versmissen's work include Blood Pressure and Hypertension Studies (24 papers), Lipoproteins and Cardiovascular Health (19 papers) and Medication Adherence and Compliance (13 papers). Jorie Versmissen is often cited by papers focused on Blood Pressure and Hypertension Studies (24 papers), Lipoproteins and Cardiovascular Health (19 papers) and Medication Adherence and Compliance (13 papers). Jorie Versmissen collaborates with scholars based in Netherlands, United States and Australia. Jorie Versmissen's co-authors include Eric J.G. Sijbrands, Daniëlla M. Oosterveer, Mojgan Yazdanpanah, Wim J. van der Giessen, Jaco H. Houtgraaf, Joep C. Defesche, J.J.P. Kastelein, Anho Liem, Peter Lansberg and Jan Heeringa and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Circulation Research.

In The Last Decade

Jorie Versmissen

86 papers receiving 2.0k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

2008 524 citations Jorie Versmissen, Daniëlla M. Oosterveer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorie Versmissen Netherlands	21	855	675	399	331	308	94	2.0k
Kathleen Wyne United States	21	986 1.2×	460 0.7×	994 2.5×	272 0.8×	565 1.8×	64	2.5k
Claudia Lamina Austria	29	853 1.0×	519 0.8×	524 1.3×	218 0.7×	412 1.3×	108	2.4k
Antonio J. Vallejo‐Vaz Spain	19	877 1.0×	369 0.5×	469 1.2×	282 0.9×	123 0.4×	51	1.5k
Núria Plana Spain	29	1.4k 1.6×	689 1.0×	859 2.2×	461 1.4×	726 2.4×	161	2.9k
George A. Stouffer United States	36	1.1k 1.2×	2.0k 2.9×	391 1.0×	271 0.8×	768 2.5×	187	4.0k
Jong-Soon Park United States	12	793 0.9×	375 0.6×	632 1.6×	133 0.4×	198 0.6×	27	1.7k
Teik Chye Ooi Canada	27	1.2k 1.3×	633 0.9×	1.0k 2.6×	309 0.9×	361 1.2×	79	2.4k
Jeanine E. Roeters van Lennep Netherlands	33	1.6k 1.9×	1.2k 1.8×	885 2.2×	482 1.5×	206 0.7×	182	3.8k
Jemma C. Hopewell United Kingdom	22	766 0.9×	428 0.6×	420 1.1×	262 0.8×	314 1.0×	58	1.8k
Danish Saleheen Pakistan	22	796 0.9×	782 1.2×	561 1.4×	303 0.9×	410 1.3×	45	2.4k

Countries citing papers authored by Jorie Versmissen

Since Specialization

Citations

This map shows the geographic impact of Jorie Versmissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorie Versmissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorie Versmissen more than expected).

Fields of papers citing papers by Jorie Versmissen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorie Versmissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorie Versmissen. The network helps show where Jorie Versmissen may publish in the future.

Co-authorship network of co-authors of Jorie Versmissen

This figure shows the co-authorship network connecting the top 25 collaborators of Jorie Versmissen. A scholar is included among the top collaborators of Jorie Versmissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorie Versmissen. Jorie Versmissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mathijssen, Ron H.J., et al.. (2025). Mechanisms of anti-VEGF therapy-induced kidney injury: current insights and future perspectives in combination with immune checkpoint inhibitors. American Journal of Physiology-Renal Physiology. 329(2). F284–F299.

Verberk, Iris, et al.. (2024). Home blood pressure telemonitoring in the Netherlands: a pilot study in GP practices. SHILAP Revista de lepidopterología. 2(1).

Kuy, P.H.M. van der, et al.. (2023). Do junior doctors make more prescribing errors than experienced doctors when prescribing electronically using a computerised physician order entry system combined with a clinical decision support system? A cross-sectional study. European Journal of Hospital Pharmacy. 32(1). 41–45. 1 indexed citations

Rubio‐Beltrán, Eloísa, Catharina C. M. Schuiling‐Veninga, Birgit C. P. Koch, et al.. (2022). Trigeminovascular effects of propranolol in men and women, role for sex steroids. Annals of Clinical and Translational Neurology. 9(9). 1405–1416. 7 indexed citations

Peeters, Laura, et al.. (2022). DiffErenCes in AntihypertenSive Drug Blood Levels in Patients with HypertensiON (DECISION): Protocol for a Prospective Observational Study Comparing Pharmacokinetics and Pharmacodynamics Between Young and Elderly Patients. High Blood Pressure & Cardiovascular Prevention. 29(3). 239–243. 3 indexed citations

Mian, Paola, Sam Schoenmakers, Robert B. Flint, et al.. (2022). Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. European Journal of Clinical Pharmacology. 78(11). 1763–1776. 17 indexed citations

Doorn, Leni van, Katrina M. Mirabito Colafella, Stijn L.W. Koolen, et al.. (2022). Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension. British Journal of Cancer. 128(2). 354–362. 7 indexed citations

Colafella, Katrina M. Mirabito, et al.. (2021). The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials. Clinical and Translational Science. 14(6). 2193–2199. 2 indexed citations

Sablerolles, Roos S. G., Melvin Lafeber, Sander D. Borgsteede, et al.. (2020). COvid MEdicaTion (COMET) study: protocol for a cohort study. European Journal of Hospital Pharmacy. 27(4). 191–193. 3 indexed citations

10.

Wassenberg, Tessa, Jaap Deinum, Frans J. van Ittersum, et al.. (2020). Clinical presentation and long‐term follow‐up of dopamine beta hydroxylase deficiency. Journal of Inherited Metabolic Disease. 44(3). 554–565. 11 indexed citations

11.

Boersma, Eric, Maryam Kavousi, Jolien W. Roos‐Hesselink, et al.. (2020). Efficacy and Safety of High Potent P2Y ₁₂ Inhibitors Prasugrel and Ticagrelor in Patients With Coronary Heart Disease Treated With Dual Antiplatelet Therapy: A Sex‐Specific Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 9(4). e014457–e014457. 21 indexed citations

12.

Boersma, Eric, Maryam Kavousi, Loes E. Visser, et al.. (2020). Reporting of sex-specific outcomes in trials of interventions for cardiovascular disease: Has there been progress?. Maturitas. 144. 1–3. 9 indexed citations

13.

Schol‐Gelok, Suzanne, Lidia R. Arends, Eric Boersma, et al.. (2019). A revised systematic review and meta‐analysis on the effect of statins on D‐dimer levels. European Journal of Clinical Investigation. 49(8). e13130–e13130. 13 indexed citations

14.

Bahmany, Soma, et al.. (2019). Simultaneous quantification of ambrisentan, macitentan and sitaxentan in human plasma using UPLC–MS/MS. Biomedical Chromatography. 34(3). e4787–e4787. 2 indexed citations

15.

Peeters, Laura, Lida Feyz, Patricia M. L. A. van den Bemt, et al.. (2019). Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertension. Expert Opinion on Drug Metabolism & Toxicology. 15(4). 287–297. 18 indexed citations

16.

Feyz, Lida, Soma Bahmany, Joost Daemen, et al.. (2018). Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in 3 Nonadherent Patients. Journal of Cardiovascular Pharmacology. 72(2). 117–120. 3 indexed citations

17.

Versmissen, Jorie, Hendrik Koffijberg, Jos Aarts, et al.. (2018). Effects of training physicians in electronic prescribing in the outpatient setting on clinical, learning and behavioural outcomes: a cluster randomized trial. British Journal of Clinical Pharmacology. 84(6). 1187–1197. 7 indexed citations

18.

Alsma, Jelmer, Anniek Brink, Soma Bahmany, et al.. (2017). [PP.05.12] DRUG NON-ADHERENCE AS MAJOR CAUSE OF SEVERE HYPERTENSION AT THE EMERGENCY DEPARTMENT. Journal of Hypertension. 35(Supplement 2). e123–e123.

19.

Nagel, Bart C.H. van der, Jorie Versmissen, Soma Bahmany, Teun van Gelder, & Birgit C. P. Koch. (2017). High-throughput quantification of 8 antihypertensive drugs and active metabolites in human plasma using UPLC–MS/MS. Journal of Chromatography B. 1060. 367–373. 34 indexed citations

20.

Net, Jeroen B. van der, Jorie Versmissen, Daniëlla M. Oosterveer, et al.. (2008). Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia. Atherosclerosis. 203(2). 472–478. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact